Dollar firms, global stocks soar on ECB rate cut expectations
NEW YORK (Reuters) – U.S. and European stocks surged on Friday on expectations the European Central Bank will cut interest rates but the dollar pared gains against the euro after…
by October Gallery
NEW YORK (Reuters) – U.S. and European stocks surged on Friday on expectations the European Central Bank will cut interest rates but the dollar pared gains against the euro after…
NEW YORK (Reuters) – Lower U.S. interest rates could help support outperforming U.S. homebuilder stocks, even as they raise worries about the economy, while a bonanza of industry data and…
NEW YORK (Reuters) – Lower U.S. interest rates could help support outperforming U.S. homebuilder stocks, even as they raise worries about the economy, while a bonanza of industry data and…
BEIJING (Reuters) – China’s economy stumbled more sharply than expected in July, with industrial output growth cooling to a more than 17-year low, as the intensifying U.S. trade war took…
WASHINGTON (Reuters) – The U.S. government’s deficit widened to $120 billion in July, fueled by increases in spending on health care and the military, according to data released on Monday…
WINDSOR, Ontario (Reuters) – U.S. Senator and Democratic presidential hopeful Bernie Sanders joined diabetes patients as they drove across the border on Sunday to buy cheap insulin in Canada, highlighting…
WASHINGTON (Reuters) – U.S. retail sales increased more than expected in June, pointing to strong consumer spending, which could help to blunt some of the drag on the economy from…
NEW YORK (Reuters) – Two former executives at American Realty Capital Properties Inc, including the onetime billionaire who built it, have reached more than $60 million in settlements with the…
(Reuters) – Drugmaker Indivior Plc said on Thursday its former parent Reckitt Benckiser’s $1.4 billion settlement with authorities in the United States was separate to its ongoing legal proceedings. Reckitt…
FRANKFURT (Reuters) – German biotech firm BioNTech has secured $325 million in a private financing round to boost its cancer immunotherapies pipeline, the company said on Tuesday. Two-thirds of the…